You Searched For "Rossari Biotech financial data" and got 20 results
Sort By:
Inside Rossari Biotech earnings: Input cost falls twice as much as revenue
Rossari recorded 14.3% fall in revenue to ₹109.4 crore but its net profit grew 7.4% to ₹15.2 cro…
AI could help predict the financial earnings of companies as large as Apple, researchers say
A group of University of Chicago researchers found that GPT-4 outperformed human financial analysts…
Lloyd Lee
Here's why Rossari Biotech bought Unitop Chemicals for ₹421 crore
The company’s share price is up by 2.5% as of 12:30pm on June 3, after the announcement. "We bel…
Concord Biotech’s IPO subscribed almost 25x with good interest from QIBs
Ahmedabad-based pharma company Concord Biotech received a tepid response from investors on the firs…
Top stocks to watch— Future Retail, IndiGo, SpiceJet, Tata Motors, IndusInd Bank, Coal India, Engineers India, Rossari Biotech, Vodafone-Idea and more
Indian stock market is likely to open on a muted amidst mixed cues from global peers. At 8:00 am th…
Top stock movers — Future Enterprises, HAL, Suntek, Oberoi Realty, M&M, ICICI Bank, Maruti Suzuki, Bajaj Auto and more
Indian benchmark stock index, Sensex advanced over 175 points in early trade on Thursday, led by fi…
Top stocks to watch on Monday— Indiabulls Housing Finance, Future Enterprises, RIL, Tata Power, Dixon Tech, Rossari Biotech and more
Indian stock-market indices are likely to open in green on Monday, on the back of positive cues fro…
Everything you need to know about the biotech market's meltdown — and how companies can survive it
Biotech has been hit hard by the recent downturn. Here's what you need to know about how public and…
Leah Rosenbaum
TikTok employees spied on US journalists
ByteDance, the Chinese parent company of TikTok, said on Thursday that an internal investigation fo…
ANI
Denmark's first meme stock plunges another 37% as a key broker warns of the risks extreme trading poses to investors
The small biotech firm, which was popular on Reddit, saw its market value jump from $200 million in…
Shalini Nagarajan
Mutual funds tank up on financial services and retail stocks
Mutual funds raised stakes in the financial services sector as economic activity and consumer deman…
VCs warn of a glut of cancer startups
These are Insider's biggest healthcare stories for August 17.
Lydia Ramsey Pflanzer
Delta's surging and antibodies are waning: What to know about when we'll need COVID-19 booster shots
Pharma companies are advocating COVID-19 boosters, but not all experts are convinced. Here's the la…
Andrew Dunn
Moderna says we'll need COVID-19 booster shots this fall, predicting that protection from its vaccine will wane
"We really do believe the virus is here to stay for the long term," a top Moderna executive said.
Andrew Dunn
Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year
Despite more attention being paid to diversity efforts, 92% of top biopharma CEOs are men, an Insid…
Shelby Livingston,Andrew Dunn
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
Biogen plummets 32% after its Alzheimer's therapy fails to win support from FDA advisory committee
The committee voted 8-1 that data from a Biogen study evaluating patients with mild Alzheimer's was…
Matthew Fox
The FDA just approved the first new Alzheimer's drug in 18 years
The Food and Drug Administration approved Biogen's Alzheimer's disease treatment even though outsid…
Allison DeAngelis
Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report
Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…
A biotech makes a $7.2 billion bet on medical marijuana
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…